When Drug Pricing Ignores Biology: Why the MFN Rule Could Hurt the Communities It Claims to Help
What if a policy meant to lower drug prices actually made it harder to get life-saving treatments—especially for communities already facing major health disparities? That’s the warning laid out in […]
